ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Identical Kidneys Are Discarded at Higher Rates When Labeled as High KDPI

    C. Crannell, J. Perkins, C. Kling

  • Identification of a Donor Kidney with Heterozygous COL4A3-related Alport Syndrome in a Homozygous Recipient Highlighting the Importance of Genetic Testing

    K. Alrejjal1, U. Abdullatif1, L. Beretich2, H. Tabriziani2, A. Abdellatif3

  • Identification of a Human B Cell State with Allogeneic Antigen Cross-Presenting Potential

    U. Bhatia, E. C. Guinan

  • Identification Of A Novel Peripheral Blood Six-gene Signature Diagnosing Subclinical Acute Rejection After Renal Transplantation

    H. Zhang, Y. Xu, Y. Wang, X. Hu

  • Identification of a Unique and Mechanistic Urinary Cell mRNA Signature in Tolerant Kidney Transplant Recipients Conditioned with FCR001 Facilitating Cells

    J. Lee1, J. R. Leventhal2, C. Li3, R. Ding1, S. Ildstad4, M. Suthanthiran5

  • Identification of Akkermansia Muciniphila and Bacteroides Thetaiotaomicron Associated with the Alleviation of Peritransplant Liver Damage in Mouse Recipients

    K. Dery1, H. Kojima2, H. Hirao2, K. Kadono3, T. Dong2, J. Kupiec-Weglinski4

  • Identification of Highly-Effective Donor-Reactive CD4+CD8αlo T Cells in CTLA4Ig-Treated Renal Allograft Recipient Monkeys

    M. Kubo, K. Sasaki, L. Lu, V. Vujevich, A. Thomson, M. Ezzelarab

  • Identification of Soluble and Cellular Biomarkers in Blood of End-Stage Patients Before Pediatric Liver Transplantation (pLTx)

    E. Chichelnitskiy1, L. Ruhl2, I. Goldschmidt3, A. Karch4, L. Antiga5, D. Debray6, L. Hierro7, D. Kelly8, V. McLin9, E. Nicastro5, J. Pawlowska10, R. Mikolajczyk11, U. Baumann12, C. Falk13

  • Identifying Health System-Level Barriers to Living Donor Kidney Transplantation: A Cross-Sectional Survey of Health Professionals

    S. Sandal1, I. Schiller1, N. Dendukuri1, J. Robert1, K. Katergi1, A. Alam1, M. Cantarovich1, J. F. Fiore Jr1, C. Weber1, M. Fortin2

  • Identifying Predictors of Pediatric Heart Only versus Combined Heart-Liver Transplantation

    K. Zhang, S. Chen, A. Syed, A. Gallo, C. Esquivel, C. Bonham, S. Hollander, M. Ma, J. Han, N. Ebel

  • Iguratimod Alleviates Endothelial to Mesenchymal Transition by Inducing AMBRA1/PARKIN-Dependent Mitophagy and Inhibiting NLRP3 Activation During Renal Allograft Interstitial Fibrosis

    Z. Gui1, W. Zijie2, M. Zheng3, R. Tan3, M. Gu4

  • Ikaros-SIRT1 Signaling Axis Regulates Macrophage Pyroptosis and Ischemia-Reperfusion Injury (IRI) in Mouse and Human Liver Transplantation

    K. Kadono1, H. Hirao1, H. Kojima1, K. J. Dery1, X. Li2, J. Kupiec-Weglinski1

  • IL-15 Signaling is Required for the Maintenance of Tissue Resident Memory T Cells in Chronic Allograft Rejection

    R. Tieu1, Q. Zeng1, D. Zhao1, A. Williams1, J. Yun Tso2, F. Lakkis1, J. Yun Tso2

  • Il-33 Induced Regulatory Macrophages Inhibit Transplantation Immune Rejection by Inducing Tregs

    J. Wu, F. Zhang, W. Wang

  • Immune Cell Phenotype of Acute Rejection of Pancreas Allografts by RNA Sequencing Analysis

    C. Hughes, H. Yang, C. Snopkowski, C. Li, D. M. Dadhania, S. Sultan, C. Hartono, M. Suthanthiran, S. V. Seshan, T. Muthukumar

  • Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas

    A. Baquerizo1, V. Vavinskaya2, S. Bagsic1, A. Rojas3, A. Mhoyan4, C. Frenette1, L. Sher5, M. Romero3, J. Fisher1, C. Marsch1, R. Schaffer1

  • Immunity Rates to Hepatitis B Among Solid Organ Transplant Recipients

    S. Kopf1, J. Walker2, K. Bruxvoort3, H. Budhwani3, A. Nellore4

  • Immunogenicity and Safety of SARS-CoV-2 Vaccines and Breakthrough Infections Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis

    A. Villavicencio1, Y. Ebisu2, M. Raja3, A. P. Sanchez-Covarrubias1, S. Anjan3, J. M. Reynolds1, J. Simkins3, J. Camargo3, M. I. Morris3, L. Abbo4, G. Guerra5, Y. Natori6

  • Immunogenicity of a 3rd Dose of Mrna Covid-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond to 2 Prior Doses

    W. Werbel1, A. Karaba1, T. Chiang1, T. Liang1, A. Massie1, M. Bettinotti1, W. Clarke1, N. Watson2, A. Tobian1, C. Durand1, N. Bridges2, D. Rostrosen2, C. Larsen3, P. Heeger4, D. Segev1

  • Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Pediatric Kidney and Liver Transplant Recipients

    T. Kitano1, K. Schwartz2, M. Abdulnoor1, H. Garfield3, N. K. Booran1, Y. Avitzur1, C. Teoh1, D. Hebert4, U. Allen3

  • Immunoglobulin M (IgM) Inhibits Replication of SARS-CoV-2 In Vero E6 Cells In Vitro and Delays Disease in K18-hACE2 Mice Infected with SARSCoV-2 In Vivo

    P. Chhabra1, B. Mann2, M. Ma1, S. Feldman3, K. L. Brayman1

  • Immunometabolism of Regulatory T Cells Enhanced by Lipid Nanoparticles

    J. S. Rink1, Y. Sambandam2, J. He2, J. Mathew3, J. R. Leventhal4, C. S. Thaxton5

  • Immunomodulation in Lung Transplant May Facilitate Transformation of Usual Interstitial Pneumonia Into Pleuroparenchymal Fibroelastosis

    Q. Cai1, K. Batra2, J. R. Torrealba1

  • Immunomodulatory Effects of Probiotic Bifidobacterium Bifidum with Tacrolimus and Sirolimus in Mouse Skin Graft Model

    A. Han1, C. Chung2, H. Kim3, H. Ko4, E. Jo1, S. Min1, S. Kim5, H. Park5, J. Ha1

  • Immunosuppressant Medications Use in Patients with Transplant Failure: A Canadian Multi-Centre Prospective Study

    G. Knoll1, M. Chassé2, D. Fergusson3, A. A. House4, O. Johnston5, R. Mainra6, D. Baran7, D. Treleaven8, l. senecal9, L. Tibbles10, M. Hebert11, M. Karpinski12, T. Campbell13, T. Ramsay14, J. Kim15, I. Houde16, C. White17, J. Perl15, P. Karnabi18, J. Gill5

  • Immunosuppressants Alter Lymph Node Architecture and Create Distinct Microbiome Footprints

    S. J. Gavzy1, R. Lakhan2, J. Iyyathurai2, V. Saxena2, L. Li2, B. Ma2, E. Mongodin2, J. S. Bromberg2

  • Immunotherapy Before Solid Organ Transplantation: An International Transplant Community-Focused Survey

    T. Ivanics1, M. P. Claasen1, D. Al-Adra2, G. Sapisochin3

  • Impact and Consequences of Recipient Gastroduodenal Artery (GDA) Ligation Prior to Hepatic Artery (HA) Anastomosis During Orthotopic Liver Transplantation (OLT)

    A. Kumar, D. Gerber, C. Desai

  • Impact of a Pharmacist on Transitions and Ambulatory Outcomes in Lung Transplant Recipients

    A. Yang, R. McKnight, A. Prom, M. Byrne, R. Evans, C. Doligalski

  • Impact of a Pharmacy-Led Post-Transplant Diabetes Mellitus Clinic in Solid Organ Transplant Recipients

    H. Sweiss1, R. Hall1, M. Flores2, S. Bhayana1, R. Patel1, C. Long2

  • Impact of a Transplant Pharmacy Collaborative Practice Agreement Implementation on an Institutional Medication Assistance Program Funding Utilization

    A. D. Kataria1, T. Sam1, N. Wilson1, A. Lee2, L. Cole2, D. Francis3, L. Zuniga3, B. Stein3, R. Goldstein3

  • Impact of African American Race on Lcp-Tac Dosing and Clinical Outcomes

    T. Sprague, F. Bartlett, J. Newman, S. Patel, N. Rao, E. Andrande, V. Rohan, D. Dubay, M. Casey, D. Taber

  • Impact Of Antifungal Prophylaxis Discontinuation On Immunosuppression In Lung Transplant Recipients

    R. Huntsman, K. Neuhaus

  • Impact of Arterial Reconstruction Technique on Hepatic Arterial Thrombosis in a Decade of Pediatric Liver Transplantation

    A. M. Delman1, Z. Farooqi1, E. Schepers1, A. Bondoc2, G. Tiao2, B. Mullapudi2

  • Impact of ATG Dose Reduction on Kidney Transplant Outcomes During the Covid-19 Pandemic

    P. A. Than1, F. De Leon1, K. Jen2, N. Goussous1, R. V. Perez1, A. X. Wang3

  • Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients

    E. R. Brown, K. Cunningham, K. Paplaczyk, C. Dagostino, C. Kane, A. Shetty

  • Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection

    L. Zaffiri, R. Hallak, S. Leonard, M. Neely, A. Hulber, H. Berry, K. A. Young, J. M. Reynolds

  • Impact of Biliary Reconstruction on Tacrolimus Absorption in Pediatric Liver Transplant

    M. Chandran1, D. Yoeli1, A. Sater2, M. Adams1, F. Karrer1

  • Impact of Changing Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function

    I. Mahaparn, R. Lepping, R. N. Montgomery, R. Mukherjee, S. Billinger, W. M. Brooks, A. Gupta

  • Impact of Cold Ischemia Times on 1 Year Kidney Transplant Outcomes

    T. Fletchinger, L. Burdine

  • Impact of COVID on Transplant Professionalism

    A. Luxon1, D. Brennan2, F. Latif3, M. Flattery4, S. Aryal5

  • Impact of COVID-19 on Increased Mortality in Liver Transplant Recipients in United States

    K. Okumura, A. Dhand, R. Misawa, H. Sogawa, R. Bodin, D. C. Wolf, S. Nishida

  • Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation

    D. J. Taber, T. Carcella, N. Patel, F. Bartlett, A. Posadas, V. Rao, M. Casey, V. Rohan, D. Dubay, D. Taber

  • Impact of Cytomegalovirus and BK Virus Infection on Clinical Outcomes in Kidney Transplant Recipients

    W. Park, J. Yang, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

  • Impact of Cytomegalovirus Infection on mRNA Expression Utilizing the Molecular Microscope in Heart Transplant Recipients

    S. S. Patlolla, J. Van Zyl, K. Castro, S. Mckean, R. Patel, S. Carey, A. Alam, S. Hall

  • Impact of Delayed Graft Function in Donation After Circulatory Death Kidney Transplantation

    J. Mello Offerni1, H. Brar1, D. Lee1, M. Levine2, M. Mandurah1, S. Rim1, A. Sener1, P. Luke1

  • Impact of Donor and Recipient Characteristics on Early Post-Transplant Donor-Derived Cell-Free DNA (dd-cfDNA) Scores

    A. Alam1, J. Zeng2, J. Teuteberg3, S. Hall1

  • Impact of Donor Quality on Outcomes for AKI and Non-AKI Kidneys with and without DGF

    C. Jadlowiec1, P. Budhiraja2, R. Butterfield1, M. Smith3, A. K. Mathur1, A. Moss1, H. Khamash2, K. Reddy1, R. Heilman2

  • Impact of Donor Type, Cold Ischemia Time, and Induction Type on Baseline Donor-Derived Cell-Free DNA in Kidney Transplant Recipients

    K. K. Sureshkumar1, A. Grazier2, B. Chopra1

  • Impact of Donor-Recipient Age Discrepancy in Living Donor Kidney Transplantation – The Need for Better Matching

    N. K. Prabhu1, V. Villani1, K. P. Samy1, D. Sudan1, K. Ravindra1, W. Irish2

  • Impact of Donor-to-Recipient Body Surface Area Ratio on Graft Survival and Mortality Following Deceased Donor Liver Transplants

    S. Radomski, L. Zeiser, A. Massie, S. Ottmann, D. Segev, E. King

  • Impact of Dysgeusia on Transplant Recipients with Refractory Cytomegalovirus with/without Resistance Receiving Maribavir: Post-Hoc Analyses from a Phase 3 Randomized Trial

    F. Silveira1, S. Haider2, D. Kaul3, O. Witzke4, J. Gu5, A. Sundberg5

  • Impact of Early Calcineurin-Inhibitor Conversion to Belatacept on Renal Allograft Function in a Steroid-Free Maintenance Regimen: Results from a Randomized Controlled Study

    I. Tawhari1, P. Hallak1, S. Hartzell2, V. Mas3, P. Cravedi2, J. Leventhal1, J. Ansari1, L. Gallon1

  • Impact of Early Corticosteroid Withdrawal on Simultaneous Pancreas-Kidney Transplant Long-Term Outcomes: Single Center Experience and Comparison to the International Pancreas Transplant Registry

    D. Pierce1, A. Lichvar2, A. Gruessner3, I. Tang1, P. DiCocco1, M. Spaggiari1, I. Tzvetanov4, E. Benedetti1, M. Campara1

  • Impact of Early versus Late Initiation of Sirolimus Regimens on Mortality After Kidney Transplantation: Age-Stratified Analyses of Adult Recipients

    A. Santos1, H. Ibrahim1, M. A. Leghrouz1, X. Wen2

  • Impact of End-of-Chain Kidney Allocation on Access to Kidney Transplantation of Minority Patients: Implications for Reducing Disparities

    J. Wade1, K. Rancourt2, A. Anane2, A. Landeen2, J. U. Singh3, X. Ye3, J. Tremaglio3, Z. Ebcioglu3, R. Kent3, B. Emmanuel4, G. Morgan4, O. K. Serrano4, W. Dar4

  • Impact of Glecaprevir/Pibrentasvir on Tacrolimus Concentration in Solid Organ Transplant Recipients with or without Triazole Antifungal Therapy

    D. Abraham1, A. Feist2, N. Law1, S. Aslam1, V. Nguyen1

  • Impact of Graft Type, Presence and Type of Inflammatory Bowel Disease on Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis

    S. Kumar1, S. Lin2, J. D. Schold3

  • Impact of HLA Matching on Graft Survival in Kidney Transplant Recipients

    J. Miller1, N. Salkowski1, B. Thompson1, R. Kandaswamy2, P. Stock3, A. Israni1

  • Impact of HMGB-1 SNPs on Comorbidities and Postoperative Complications in Liver Transplant Recipients

    N. Tsukiyama1, Y. Tanaka1, Y. Imaoka1, A. Seidakhmetov1, R. Nakano1, N. Tanimine1, D. Marlen1, M. Ohira2, H. Tahara1, K. Ide1, H. Ohdan1

  • Impact of Immunosuppression on T-cell Responses After mRNA-Based Sars-CoV-2 Vaccination

    E. Wong1, N. L. Bert2, H. K. Sran1, A. Lim1, M. D'Costa1, K. Akalya2, S. Hang2, A. Bertoletti2, A. Vathsala1

  • Impact of Immunosuppressive Medications on SARS-CoV-2 Vaccination Response in Kidney Transplant Patients

    O. Sogbein1, A. Rizvi2, M. Mujtaba3, M. Kueht4, J. Fair4, A. Gamilla-Crudo3, S. Hussain5

  • Impact of Induction Immunosuppression on Renal Recovery in Adult Liver Transplant Recipients – A Single Center Experience

    T. Zurick1, D. Bruno2, D. Kumar3, R. Winstead1, C. Song1, A. Brown1, S. Sterling1, I. Yakubu1

  • Impact of Kidney Allocation Change on Low Volume Kidney Transplant Centers

    S. Nagaraju1, S. Vaishnav1, S. A. Deslich2, S. Hanna1, A. Jones3, J. B. Africa1

  • Impact of Kidney Transplant on Post-Operative Morbidity and Mortality in Patients with Pre-Existing Cardiac Conditions (Low Ejection Fraction): A Case Series

    A. Kumar, C. Naso, D. Bacon, D. Gerber

  • Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes

    M. Pacaud1, L. Colas1, C. Kerleau2, F. Le Borgne3, M. Giral2, S. Brouard1, J. Dantal2

  • Impact of Long Agonal Duration on Outcomes After Donation After Circulatory Death Lung Transplantation: An Analysis of the United Network of Organ Sharing Database

    J. Thomas, Q. Chen, J. Chikwe, D. Emerson, D. Megna, P. Catarino

  • Impact of Low Dose Donor-Specific HLA Antibodies in Living and Deceased Donor Kidney Transplantation

    H. Lee1, I. Sun2, C. Yang1, B. Chung1

  • Impact of Maintaining Blood Pressure Goals on Graft Function After Kidney Transplant

    D. Majmundar, A. DiCarlo, S. Karhadkar, A. Diamond, K. Mohrien, P. Szczesniak

  • Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center

    S. Kodali1, D. W. Victor2, J. Corkrean2, A. Shetty2, C. Mobley2, M. Hobeika2, R. McMillan2, E. A. Graviss3, D. T. Nguyen3, R. McFadden4, V. Ankoma-Sey2, C. Egwim5, J. Galati2, A. Saharia2, R. M. Ghobrial2

  • Impact of Mycetoma in Lung Transplant Recipients

    A. Majeed, S. Singh, J. Lum

  • Impact Of Nirmatrelvir-Ritonavir On Tacrolimus Concentrations

    S. Fredrick1, B. Wise2, L. Bowman2, D. DeWolfe1, J. Taylor1, J. Melaragno1

  • Impact of Novel Social Factors on Living Kidney Donation

    L. Cholin, E. Ramos, J. Yahr, J. Schold, E. Poggio, A. Huml

  • Impact of Pretransplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates

    J. Jarrah, Z. Hanna, J. Williams, J. McCorquodale, T. Párraga, S. Greenlee, O. Abreu Lanfranco, M. Ramesh, R. del Busto, G. Alangaden

  • Impact of Recipient Obesity on Kidney Transplantation Outcome: A Retrospective Cohort Study with a Matched Comparison

    A. Buemi

  • Impact of Recipient Warm Ischemic Time on Outcomes Associated with High KDPI and DCD Donor Kidneys: Cold Ischemic Time Remains Paramount

    M. L. Jacobs, R. Stratta, M. Garner, B. Sharda, A. Farney, G. Orlando, A. Reeves-Daniel, C. Jay

  • Impact of Removing DSA and OPTN Region from Pancreas Allocation

    S. E. Booker1, A. Robinson1, K. Gauntt1, J. White1, S. Niederhaus2, O. Olaitan3, R. Forbes4

  • Impact of Respiratory Viral Panel Testing on Clinical Decision-Making Among Lung Transplant Recipients Based on Extent of Immunosuppression

    A. C. Vostal1, A. Lynen2, S. Chintalapati1, M. Uehling1, K. Prakash2, A. Shishido1, J. Baghdadi2

  • Impact of Sarcopenia Using L3 and Thigh Skeletal Muscle Index on Clinical Outcomes in Liver Transplantation Recipient

    M. Lim, J. Kim

  • Impact of Sars-CoV-2 Vaccination on Donor-Derived Cell Free DNA Levels in Renal Transplant Recipients

    H. Alvarado Verduzco, E. Daniel, D. Kim, A. Hussain, S. Mohan, D. Cohen

  • Impact of Sub-therapeutic Tacrolimus Troughs at Discharge from Index Admission on Short-Term Outcomes in Kidney Transplant Recipients Receiving Rabbit Anti-Thymocyte Globulin Induction

    X. Liu1, J. Trofe-Clark2, D. Sawinski3, B. Steiner1, S. Sharma1, S. Witek1, T. Fallah2, M. Norris2, C. Sammons2, G. Malat2

  • Impact of Target Tacrolimus Levels on BK Polyomavirus DNAemia and Allograft Rejection Among Pediatric Kidney Transplant Recipients

    H. Huang1, P. Winterberg1, R. George1, A. Serluco2, R. Liverman2, I. Yildirim3, R. Garro1

  • Impact of the COVID-19 Pandemic on CMS Organ Procurement Organization Performance Metrics

    N. Dzebisashvili1, K. Lentine2, D. Axelrod3, K. Venkataramani1, K. Axelrod1, M. A. Schnitzler2

  • Impact of the Covid-19 Pandemic on Longitudinal Molecular Surveillance in the KOAR Registry

    T. Alhamad1, A. Malone1, D. Mandelbrot2, P. M. Anand3, H. M. Wadei4, G. Shekhtman5, N. Agrawal5, K. Pinney5, K. Qu5, A. Desai6

  • Impact of the High Baseline Anti-a/b Antibody Titer on the Clinical Outcomes in ABO-incompatible Living Donor Liver Transplantation

    J. Cho, B. Lee, H. Lee

  • Impact of the Second Year COVID-19 Pandemic on the U.S. Kidney Transplantation: Interrupted Time Series Analysis

    E. Tantisattamo1, N. Polpichai2, P. Mutirangura3, M. Tanariyakul4

  • Impact of the Weekend Effect on Adult and Pediatric Liver or Kidney Offer Acceptance

    T. Yamamoto, M. Fruscione, A. Shah, L. Dageforde, S. Kimura, H. Yeh, N. Elias, T. Kawai, J. F. Markmann

  • Impact of Total Parenteral Nutrition on Donor Kidneys During Oxygenated Preservation at 22ºC Ex Vivo

    P. Luke1, A. Jackson2, A. Ruthirakanthan2, S. Juriasingani2, M. Levine1, L. Jiang2, R. Patel2, M. Richard-Mohamed1, S. Forrest1, A. Sener1, R. N. Bhattacharjee1

  • Impact of Varying Levels of Normal Range Baseline Donor Derived Cell Free DNA on Medium-Term Outcomes Following Kidney Transplantation

    K. K. Sureshkumar1, A. Grazier2, B. Chopra1

  • Impacts Of Donor Gender On Recurrent Hepatocellular Carcinoma In Liver Transplant Donated After Brain Death

    T. Nakamura1, K. Sasaki2, T. Yamamoto1, S. Kimura1, L. Dageforde1, H. Yeh1, N. Elias1, T. Kawai1, J. F. Markmann1

  • Impaired Cellular Immunity and Elevated Myeloid Derived Suppressor Cells in Kidney Transplant Recipients with Impaired Antibody Response to Covid-19 Vaccination

    B. Nibhanupudy1, K. Mcdonald1, M. Angelis1, L. T. Chin1, P. Wai1, R. Metzger1, C. Ashokkumar2, R. Sindhi2

  • Impaired Humoral Response to Second Dose of BNT162b2 Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients in Japan: Prospective Observational Study

    H. Sasaki1, K. Hasegawa1, M. Miura2, H. Harada1, D. Takamoto1, Y. Takada1, S. Harada1, H. Tanaka1

  • Impaired Left Ventricular Global Longitudinal Strain: Clinical Presentation and Outcomes in Liver Transplantation Recipients without Arrhythmia or Structural Heart Disease

    M. B. Hammami, J. Grossman, P. Xue, H. Allaham, K. Eagan, S. Gottlieb, C. Hong, L. Wang, C. Bhati, D. Maluf, K. Shetty, N. Urrunaga

  • Implanting a Robot-Assisted Kidney Transplant Program for ASTS Trained Transplant Surgeons with No Robotic Surgery Background

    B. Kocak1, N. Celik1, E. Arpali1, B. Akyollu1, B. Kilicer1, E. Canda2, Y. Kordan2

  • Implementation of Infectious Disease Surveillance in Recently Deceased Human Xenograft Study

    S. J. Cawthon, E. P. Weldon, N. S. Lawson, B. E. Lonze, R. A. Montgomery, S. A. Mehta

  • Implementation of Modified Multi-Point Screening in Selection Criteria for Kidney Transplant Candidates

    M. E. Welborn, S. Thuppal, K. Delfino, R. Bounds, M. Hazelrigg, M. R. Garfinkel

  • Implementation of Robotic Approach for Living Donor Nephrectomy in a High-Volume Laparoscopic Centre

    G. Papadakis1, I. D. Kostakis2, A. Kumar1, P. Kotecha3, P. Gogalniceanu1, N. Mamode1, J. Olsburgh1, B. Challacombe1, N. Kessaris1, I. Loukopoulos1

  • Implementing Clinical Decision Support Tools for Immunosuppressant Drug-Drug Interactions to Prevent Graft Failure

    A. Yishak1, S. Ledan2, S. Mukherjee3, C. Chen2, A. Ayoola2, T. Kim2, A. Olenik2, K. Mullican2, A. Henje2, N. Lorence2, L. Beckman2

  • Implementing Genetic Testing in the Evaluation of the Kidney Transplant Candidate

    F. Abu Al Rub1, Y. Caliskan2, H. Randall2, B. Bastani2, V. Fleetwood3, M. Nazzal2, C. Varma2, K. Lentine2

  • Implications of Accumulated Cold Time for US Kidney Transplantation Offer Acceptance

    M. Barah1, V. Kilambi2, J. Friedewald1, S. Mehrotra1

  • Implications of Pre-Transplant (tx) COVID-19 on SOT or HCT: A Multicenter Study

    G. Haidar1, K. Hughes-Kramer2, C. Alonso3, J. Hand4, E. Blodget5, V. Srinivasa5, S. Aslam6, H. Hassouna7, C. Lawson7, M. Malinis8, S. Anjan9, E. Lease10, M. Al-Obaidi11, P. Vergidis12, J. Husson13, D. van Duin14, R. Avery15, K. Downes16, M. R. Heldman10, J. Nelson17, S. Pouch18, S. Chuang19, C. Kao20, M. Estabrook21, F. Alconchel22, S. Mazumber23, P. Samanta2, M. Wagener2, N. Singh2, F. Silveira2

  • Improved Mortality in COVID-19 Kidney Transplant Recipients Treated with Bamlanivimab

    A. Hamiduzzaman, U. Reddy

  • Improvement in Kidney Function After Early Conversion to Belatacept-Based Regimen in Allografts with Biopsy-Proven Donor Vascular Disease

    T. Ommert1, J. Javier1, J. Jackson1, C. Klein2

  • Improving Access and Equity for Transplant: A Single-Center Experience

    S. Kodali1, A. Lopez2, C. Egwim2, J. Alegria2, S. Yi2, H. Adrogue2, M. Moaddab2, H. Huang2, I. Hussain2, M. Kassi2, J. Ontiveros2, R. Guardiola2, J. Alexander2, D. Harvey2, K. Maresh2, S. Zylicz2, L. Loza2, J. Corkrean2, A. O. Gaber2, R. M. Ghobrial1

  • Improving Efficiency in Kidney Distribution: A Comparison of UNet Deceased Donor Criteria to Actual Kidney Acceptance Practices

    L. B. Zeiser, J. Ruck, D. Segev, A. Massie

  • Improving Value Delivery in Compatible Living Donor Kidney (CLD) Transplant Through Zero-Low Eplet Mismatch via National Kidney Registry (NKR)

    S. Anand1, J. Sanchez-Garcia1, W. Stapley1, J. Browning1, M. Egbert1, S. Dow1, A. Raza1, T. Srinivas2, D. Morris1

  • In Kidney Recipients from the Same Deceased Donor, Discordance in Delayed Graft Function is Associated with Poor Outcomes

    E. A. Yousif, B. Muth, V. Manchala, J. Turk, J. Blazel, M. Bloom, N. Garg, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot, S. Parajuli

  • In Vitro Fertilization Use Among Female Kidney Transplant Recipients

    L. A. Coscia1, J. M. Konel2, M. Bowring3, S. Constantinescu4, M. J. Moritz5

  • Incidence and Laterality of Pulmonary Emboli in Single Lung Transplant Recipients

    F. Pyarali1, J. Thomas2, A. Peiris2, R. Rampolla1

  • Incidence and Outcomes of CMV Infection in Pancreas Transplant with Thymoglobulin Induction: A Single Center Experience

    W. Abusalah, A. Yadav

  • Incidence and Outcomes of Fever of Unknown Origin After Kidney Transplant in the Modern Era

    M. Jorgenson, S. Parajuli, B. Astor, C. Saddler, J. Smith, D. Mandelbrot

  • Incidence and Risk Factors Associated with the Development of Hypoglycemia After Combined Pancreas-Kidney Transplantation

    S. Kapoor1, S. Jain2, S. Stefan3, Y. Azzi3, M. Ajaimy3, P. Loarte-Campos3, C. Pynadath3, H. C. Yaffe3, M. Le3, J. Rocca3, S. Greenstein3, M. Kinkhabwala3, J. Graham3, E. Akalin4, L. Liriano-Ward3

  • Incidence of Biliary Complications at the Beginning of the Academic Year in an Academic Transplant Program

    M. E. Tobon Lascano, C. J. Simon, M. E. Akoad, J. Kim, M. Simpson, Y. Cheah

  • Incidence of Dapsone-Induced Methemoglobinemia in Solid Organ Transplant Recipients

    D. Quan1, R. Gordon1, J. Lee1, D. Khoshabafard2, A. Han1

  • Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients

    D. Majmundar, S. Karhadkar, A. Diamond, J. Au, C. Ruggia-Check

  • Incidence of Delayed Graft Function in Kidneys Recovered After Normothermic Regional Perfusion

    L. James1, M. D'Angelo1, J. Carillo1, J. C. Berger1, D. E. Smith1, N. Moazami1, B. Lonze2

  • Incidence of Opportunistic Infections in Elderly Kidney Transplant Recipients on Belatacept

    K. Khalil, S. Jonchhe, J. Stern, R. Robalino, Z. A. Stewart, S. A. Mehta, N. Ali, H. Neumann

  • Incidence of Posttransplant Lymphoproliferative Disorder with Belatacept Therapy versus Calcineurin Inhibitor Therapy Alone: Data from One Academic Medical Center

    K. Addonizio1, G. Petrossian1, A. Hsiao1, L. Teixeira1, N. Koizumi2, R. James2, S. Patel3, R. Plews1, D. Conti1, J. Ortiz1

  • Incidence of Urinary Tract Infection or Asymptomatic Bacteriuria in Kidney Transplant Recipients with Sulfamethoxazole-Trimethoprim vs. Pentamidine for Pneumocystis Jiroveci Pneumonia Prophylaxis

    L. Selznick, H. Sweiss, C. Long, S. Bhayana, R. Hall

  • Incidence of Viral Infections in Kidney Transplant Recipients Using Reduced Induction and Steroid Free Maintenance Immunosuppression

    P. Dunton, L. Von Stein, H. Winters, A. Schenk, T. Pesavento, R. M. Smith, K. Schnelle

  • Increase in Exception and Extension Requests for Higher-Urgency Patients Under the New Heart Allocation Policy

    J. R. Golbus1, Y. Ahn2, B. K. Nallamothu1, M. N. Walsh3, D. Zaun2, A. Israni2, M. Colvin1

  • Increased Baboon Chimerism After Peripheral Blood Stem Cell Infusion from a Novel GalTKO Pig with Functional Humanized Il-3 Receptor

    E. M. Duggan, N. P. Llore, J. M. Stern, H. Sakai, B. Piegari, K. Bruestle, D. Hajosi, B. Bhola, F. Huang, D. Ekanayake-Alper, D. H. Sachs, M. Sykes, R. J. Hawley, A. D. Griesemer

  • Increased Costs, Cold Ischemia Time, and Sharing Associated with Removing DSA and OPTN Region from Kidney Allocation: A Single-Center Analysis

    R. Forbes1, A. Dreher1, E. Zavala2, L. A. Hickman1, L. Smith3, J. Lawson1, D. Shaffer1, B. P. Concepcion1

  • Increased Mortality After Kidney Transplantation in Mildly Frail Recipients: Need for Pretransplant Intervention

    J. Pascual Santos1, C. Arias-Cabrales1, D. Redondo-Pachón1, C. Burballa1, A. Buxeda1, A. Bach1, A. Faura1, E. Marco2, L. Rodríguez-Mañas3, M. Crespo1, M. J. Pérez-Sáez1

  • Increased Plasminogen Activator Inhibitor-1 is Associated with Less Severe Clinical Bleeding After Reperfusion During Liver Transplantation

    H. J. Braun, N. Ascher, G. Roll, J. Roberts, C. Niemann, M. Bokoch

  • Increased Regulatory T-cells in Tumor Microenvironment is Associated with Hepatocellular Carcinoma Differentiation in Patients Undergoing Liver Transplantation

    G. Orozco1, R. Gedaly2, L. Turcios2, F. Marti2

  • Increased Risk for Allograft Loss in African American Kidney Transplant Recipients After Biopsy for Chronic Allograft Dysfunction

    C. R. Dorr1, B. Wu2, B. Guo2, W. Guan2, D. Schladt1, S. Elmer1, G. Crary3, G. Onyeaghala1, W. Oetting2, G. Agarwal4, R. B. Mannon5, P. Jacobson2, A. Matas2, A. Israni3

  • Increased Survival Benefit Amongst Highest Priority Candidates Undergoing Heart Transplant Following the New Us Heart Allocation System

    S. Tolmie1, W. Parker2

  • Increased Use of DCD Liver Grafts Does Not Adversely Affect Outcomes: A Single-Center Experience

    M. Finotti, G. McKenna, H. Fernandez, J. Bayer, S. Lee, E. Martinez, N. Onaca, G. Saracino, R. Ruiz, G. Testa, A. Wall, A. Gupta

  • Increased Waitlist Mortality in Pediatric Liver Transplant Candidates with Greater Distance from Transplant Center

    C. X. Qin, T. Ishaque, S. M. Frey, A. B. Massie, A. M. Cameron, D. L. Segev, E. A. King

  • Increasing Proportion of High-Risk Cytomegalovirus (CMV) Donor Positive/recipient Negative (D+R-) Serostatus in Solid Organ Transplant Recipients (SOTRs)

    H. Imlay1, M. M. Wagener2, N. Singh2, A. P. Limaye3

  • Individual and Community-Level Social Determinants of Health in Liver Transplant

    M. Yilma1, R. Cogan2, N. Mehta3, J. Neuhaus2, J. Voelkel4, C. Light5, I. Allen2, R. Hirose2

  • Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for T2 Hepatocellular Carcinoma and May Allow for Decreased Mortality

    C. Durkin1, T. Bittermann1, D. E. Schaubel2

  • Induction Immunosuppression in ABO-Incompatible Liver Transplant Recipients

    S. Shaikh1, I. Hasan1, N. Kaur2

  • Induction of Tacrolimus Clearance by Steroids Varies by Cyp3a5 Genotype in Kidney Transplant Recipients: A Drug-Drug-Gene Interaction

    P. A. Jacobson1, A. Saqr1, M. Al-Kofahi1, D. P. Schladt2, W. Guan3, W. S. Oetting1, R. Mannon4, C. R. Dorr5, R. P. Remmel1, G. C. Onyeaghala6, B. Wu3, A. K. Israni7, A. Matas8

  • Induction of Tolerance After Intestinal Transplantation in a Porcine Model

    S. Merl, R. Jones, B. Chen, M. Sykes, K. Yamada, J. Weiner

  • Infection Impacts dd-cfDNA in Lung Transplant Recipients

    D. Levine1, C. Giner1, C. Pham2, R. Woodward2, A. Roux3

  • Infections Following Rejection Therapies in Solid Organ Transplant Recipients

    S. Gupta1, J. Gea-Banacloche2, H. Me3, D. M. Chascsa4, H. R. Vikram2, R. Yaman1, L. Kodali3

  • Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression

    S. Gattis1, A. Basu2

  • Infections Requiring Hospitalization After Simultaneous Pancreas-Kidney Transplantation Compared to Kidney Transplantation Alone

    J. Grasberger1, F. Ortiz2, A. Ekstrand2, V. Sallinen1, M. Lempinen1, I. Helanterä1

  • Infectious Disease Testing Among US Deceased Organ Donors

    A. Mezochow1, T. Bittermann1, E. Blumberg1, R. Hasz2, J. Anesi1

  • Inferior Kidney Transplant Outcomes in Young Adults Transplanted as Children

    K. Deville, F. Rosenblum, D. R. Kelly, M. Seifert

  • Infiltrating CD8+ Cytotoxic T Cells Are Converted to a Regulatory Phenotype in Accepted Kidney Allografts

    T. Yokose1, E. S. Szuter1, M. T. Guinn1, J. Ge2, I. Rosales3, M. Ford4, P. S. Russell1, A. G. Cuenca2, J. C. Madsen1, R. B. Colvin1, A. Alessandrini1

  • Inflammation After Kidney Transplantation Is Associated With Overall- And Death-censored Graft Loss

    T. F. Heldal, T. Jenssen, A. Hartmann, K. Heldal, A. Asberg

  • Influence of Converting Kidney Transplant Recipients with High Tacrolimus Variability to the Once Daily LCP Tac Formulation

    D. Taber, F. Bartlett, N. Patel, T. Sprague, S. Patel, J. Newman, E. Andrade, N. Rao, A. Posadas, V. Rao, M. Casey, D. Dubay, V. Rohan

  • Influence of Immunosuppressive Drugs on Nk Cells in Therapeutic Drug Exposured

    R. r. Qin1, C. Sun2, B. Nashan1

  • Influence of Regulatory B Cells on B Cells

    Q. Fu1, K. M. Lee2, K. Deng2, D. Agarwal1, R. Matheson3, T. Press1, J. Lei4, H. Yang5, C. LeGuern2, S. Deng5, J. F. Markmann2

  • Influence of the Competing Risk of Recipient Death on the Risk Estimation of Kidney Transplant Failure

    M. Coemans1, G. Verbeke2, B. Döhler3, C. Süsal3, M. Naesens1

  • Inhalation Alone versus Inhalation Plus Intravenous Colistin for Multidrug-Resistant Gram-Negative Bacterial Infection After Lung Transplantation

    H. Kim1, Y. Yang1, A. Woo2, S. Jeong3, S. Kim2, J. Lee1, M. Park2, H. Paik1

  • Inhibition of ITGB5 Protects Hepatocytes from Ischemia Reperfusion Injury

    M. Dogan1, S. Naik1, C. Watkins1, A. Bajwa1, V. Mas2, J. Eason3, C. Kuscu1, C. Kuscu1

  • Initial Outcome of External Biliary Drainage Tube Insertion in Living Donor Liver Transplantation: Pure Laparoscopic Donor Hepatectomy Dominant Center Experience

    E. Jang1, S. Hong1, S. Hong1, S. Lee1, S. Suh1, E. Han1, Y. Choi2, N. Yi2, K. Lee3, K. Suh4

  • Integrated Alcohol Use Disorder Clinic as a Strategy to Reduce Alcohol Relapse After Early Liver Transplantation in Patients with Alcohol Related Liver Disease

    R. Z. Syed1, C. Albers2, N. Kemmer2, V. Subramanian2, C. Machado-Denis1, K. Dhanireddy2

  • Intensive Antimetabolite Reduction is Not Associated with Increased Risk of Biopsy-Proven Acute Rejection in Kidney Transplant Recipients with BK Virus Infection; a Single Center Experience

    J. Marvin1, D. Malhotra2, P. Jethwani2, K. Belfield1, E. Cohen1

  • Interaction Between Financial Barriers and Other Motivators, Barriers, and Facilitators of Living Organ Donation

    A. R. Smith1, R. J. Mandell1, M. E. Helmuth1, N. P. Goodrich1, J. B. Wiseman1, K. A. Gifford2, M. A. Fava1, A. O. Ojo3, R. M. Merion1, A. K. Mathur4

  • Interleukin-31 (IL-31) and Leukemia Inhibitory Factor (LIF) Are Upregulated in Acute Rejection of Kidney Allograft

    I. Striz, L. Krupickova, M. Fialova, M. Novotny, E. Cecrdlova, O. Viklicky

  • Intermediate Term Outcomes of SGLT2 Inhibitors Amongst Diabetic Kidney Transplant Recipients

    C. Song1, A. Brown2, R. Winstead1, S. Sterling1, I. Yakubu2, J. Christensen2, G. Gupta2

  • Internal Validation of a Pre-Transplant Biomarker Panel to Predict Post-Transplant Mortality: The Liver Immune Frailty Index

    G. G. Panayotova1, D. T. Nguyen2, E. A. Graviss2, L. J. Minze2, S. Simonishvili1, Y. Qin1, T. Ayorinde1, G. Prakash1, F. Paterno1, L. Brown1, A. Amin1, X. C. Li2, R. M. Ghobrial2, J. V. Guarrera1, K. E. Lunsford1

  • International Practices on COVID-19 Vaccine Mandates for Transplant Candidates

    Y. Caliskan1, B. E. Hippen2, D. Axelrod3, M. Schnitzler1, K. Maher1, T. Alhamad4, S. Anwar5, V. Kute6, K. Lentine1

  • Interventional Radiology Procedures for Complications of Orthotopic Liver Retransplantation: A 22-year Single Center Experience

    A. F. Sayed Ahmed1, B. B. Toskich1, S. A. Mao2

  • Intra Portal Islet Auto Transplantation (IAT) Independently Improves Quality of Life in Patients After Total Pancreatectomy (TP) and IAT in Patients with Chronic Refractory Pancreatitis

    S. Chinnakotla, G. Beilman, D. Vock, M. Freeman, V. Kirchner, T. Pruett, S. Amateau, G. Trikudanathan, E. Downs, S. Schwarzenberg, M. Armfield, K. Ramanathan, D. Sutherland, M. Bellin

  • Intraabdominal Hypertension in the Death by Neurologic Criteria Organ Donor

    C. Schardein1, M. Moncure2, S. Craft1, S. Sanders3

  • Intraoperative Kinetics of Pro-Inflammatory Markers and Delayed-Graft Function During Kidney Transplantation

    P. A. Wadsworth, H. L. Stevenson, M. L. Kueht

  • Intrinsic DEPTOR Activity Modulates Treg Subset Differentiation

    J. Wedel1, M. Maslyar1, B. Alsairafi1, S. Kong2, D. M. Briscoe1

  • Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients

    R. Alameer, M. Nguyen, P. Samanta

  • Investigating RNA Interference-Mediated Inhibition of Liver Ischemia Reperfusion Injury During Liver Preservation

    J. E. Buchwald1, D. Echeverria2, J. Sousa2, N. McHugh2, A. Khvorova2, P. N. Martins3

  • Is a Single Dose of Steroids in Adult Living Donor Liver Transplant Safe? – A Cohort Analysis

    M. Nunez, C. Praglin, A. M. Torres, E. Agudelo, H. Braun, C. Huang, S. Syed, J. Roberts, G. Roll

  • Is Abo Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?

    C. de Magnée1, L. Brunée1, R. Tambucci1, A. Pire1, I. Scheers2, E. Sokal2, P. Baldin3, F. Zech4, S. Eeckhoudt5, R. Reding1, X. Stephenne2

  • Is BK After SPK Okay?: Kidney and Pancreas Transplant Outcomes After BK Viremia

    G. Dube1, K. McCune2, D. Cohen3, L. Ratner2, S. Husain1

  • Is Donor Hepatitis C Virus Infection Status Associated with Early Post-Kidney Transplant Failure in the Era of Direct-Acting Antiviral Medications?

    S. Sutcliffe1, S. Chang1, D. Stewart2, M. Ji3, K. Lentine4, G. Gupta5, T. Alhamad6

  • Is Pathologic AMR Grading Scale Associated with the Presence of Donor-Specific Antibodies?

    S. Kim, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, D. Chang, E. Kransdorf, D. Emerson, J. A. Kobashigawa

  • Is Remnant Liver Volume Ratio Less Than 30% Still Contraindication to Right Hepatectomy for Living Liver Donors?

    J. Kim, D. Choi

  • Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Multicenter Analysis

    M. L. Holzner1, V. Mazzaferro2, M. Droz dit Busset2, L. Aldrighetti3, F. Ratti3, K. Hasegawa4, J. Arita4, G. Sapisochin5, P. Abreu5, W. Schoening6, N. Nevermann6, M. Schmelzle6, J. Pratschke6, S. Florman1, K. Halazun7, M. E. Schwartz1, P. Tabrizian1

  • Is Stigma of Hepatitis C with KDPI Still Justified?

    F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann

  • Islet-Derived Exosomes Carry Self-Antigens and May Induce Autoimmunity After Transplantation

    S. Vasu1, C. Darden2, J. Mattke2, Y. Liu3, M. C. Lawrence3, B. Naziruddin1

  • Ixazomib for Desensitization (IXADES): Results of a Phase II Clinical Trial

    N. Wilson1, S. R. Reese2, L. Ptak3, F. Aziz2, S. Parajuli2, V. Jucaud4, S. Denham4, A. Mishra5, P. Hematti5, A. Djamali2

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences